If You Invested $10,000 in Moderna 2 Years Ago, This Is How Much You Would Have Today
Moderna (NASDAQ: MRNA) was one of the best stocks to own last year as it brought its COVID-19 vaccine to market and generated billions in revenue. The company, which was a bit of an unknown before the pandemic began, has quickly risen in popularity. And even though its shares have been declining this year, they're still up a whopping 766% since 2019.
But what if you bought the stock roughly two years ago today, after the company's vaccine was already approved? And more importantly, is the stock still a good buy now?
Two years ago, health officials weren't administering Moderna's COVID-19 vaccine yet -- the Food and Drug Administration didn't grant it Emergency Use Authorization (for people 18 years and older) until December 2020. The FDA has since expanded authorization to cover children as young as six months.
Source Fool.com
